Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Option Care Health Inc (OPCH)
:OPCH
Holding OPCH?
Track your performance easily
Earnings Data
Report Date
Feb 26, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
0.35Last Year’s EPS
0.32Same Quarter Last Year
Moderate Buy
Based on 9 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 05, 2020
|% Change Since: -4.39%
|Next Earnings Date:Nov 06, 2019
Earnings Call Sentiment|Neutral
Option Care Health reported strong financial performance with double-digit revenue growth and robust cash flow. However, significant challenges such as the IV bag supply disruption and anticipated impact from drug pricing changes in the chronic inflammatory therapies portfolio pose concerns for future profitability.Company Guidance
During the Option Care Health Q3 2024 earnings call, management provided guidance reflecting strong financial performance despite challenges. The company reported a revenue growth of 17% and adjusted EBITDA of $115.6 million, representing 9% of revenue. They ended the quarter with a net debt-to-EBITDA leverage ratio of 1.5x and cash flow from operations at $160.4 million. For the full year 2024, Option Care Health revised its revenue guidance to $4.9 billion to $4.95 billion and adjusted EBITDA to $438 million to $443 million, incorporating supply chain disruptions from Hurricane Helene impacting their operations. Despite these hurdles, the company anticipates generating at least $300 million in cash flow from operations. Looking ahead, they plan to introduce adjusted earnings per share as a financial metric starting in 2025 and will provide guidance on this metric in future calls.Double-Digit Revenue Growth
Option Care Health reported a 17% revenue growth in Q3, driven by strong growth in rare and orphan portfolios and established therapeutic categories.
Strong Cash Flow and Low Leverage
The company generated $160.4 million in cash flow from operations and ended the quarter with a net debt-to-EBITDA leverage ratio of 1.5x, the lowest since the merger with BioScrip in 2019.
Successful Stock Repurchase
Option Care Health repurchased $41.9 million in stock during the quarter, reflecting confidence in its financial position.
Adjusted Earnings Per Share Introduction
The company has begun reporting adjusted earnings per share as an additional key financial metric and plans to provide guidance on this metric starting in 2025.
---
OPCH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
OPCH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 30, 2024 | $30.50 | $23.55 | -22.79% |
| Jul 31, 2024 | $31.35 | $29.69 | -5.30% |
| Apr 23, 2024 | $30.41 | $30.59 | +0.59% |
| Feb 22, 2024 | $33.36 | $32.55 | -2.43% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Option Care Health Inc (OPCH) report earnings?
Option Care Health Inc (OPCH) is schdueled to report earning on Feb 26, 2025, TBA Not Confirmed.
What is Option Care Health Inc (OPCH) earnings time?
Option Care Health Inc (OPCH) earnings time is at Feb 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is OPCH EPS forecast?
OPCH EPS forecast for the fiscal quarter 2024 (Q4) is 0.35.
---